Monoclonal Antibody to PACAP for Migraine Prevention - Part 2

Dr. Tesha Monteith, a dedicated migraine researcher, joins Dr. Messoud Ashina, an expert in migraine treatment, to delve into a groundbreaking phase two study on a monoclonal antibody targeting PACAP for migraine prevention. They highlight its efficacy and safety compared to placebo, address the pressing need for new treatments, and share insights on reported adverse effects. The discussion also hints at exciting future research directions that could transform migraine management. This is vital listening for anyone interested in migraine solutions!